McKesson Investor Targets Execs Over Drug Price-Rigging
A shareholder of drug distributor McKesson Corp. hit the company's top brass with a derivative complaint Monday accusing executives of feathering their nests with company cash while overseeing average wholesale price...To view the full article, register now.
Already a subscriber? Click here to view full article